Yes. Lee Zeldin disclosed 1 purchase and 2 sales of NeuroSense Therapeutics (NRSN) stock between May 13, 2025 and Sep 23, 2026, in an OGE Form 278-T. Added together, the disclosed purchases come to $1K-$15K and the disclosed sales to $2K-$30K.
Yes. Lee Zeldin disclosed 1 purchase and 2 sales of NeuroSense Therapeutics (NRSN) stock between May 13, 2025 and Sep 23, 2026, in an OGE Form 278-T. Added together, the disclosed purchases come to $1K-$15K and the disclosed sales to $2K-$30K.
How big were Lee Zeldin's NeuroSense Therapeutics trades?
OGE filings report a range for each trade, such as $1K-$15K, never an exact amount. Added together, the disclosed purchases come to $1K-$15K and the disclosed sales to $2K-$30K.
Does Lee Zeldin still own NeuroSense Therapeutics stock?
This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.
When did Lee Zeldin report these trades?
The latest filing is dated Nov 21, 2026. Officials have up to 45 days after a trade to report it, so a filing can trail the trade by weeks. Every row shows both dates.
Where does this data come from?
From periodic transaction reports (OGE Form 278-T) filed with the Office of Government Ethics. Every trade links to the original filing.